Core Insights - The 2025 Brain-Computer Interface (BCI) Conference opened in Shanghai, focusing on developer events, competitions, and investment forums to enhance the connection of technology, industry, and capital resources [1] - The BCI industry is recognized for its social and commercial value, with McKinsey projecting the global medical application market to reach $40 billion by 2030 and potentially exceed $145 billion by 2040 [1] - The industry is entering a critical phase of large-scale application driven by strong policy support, continuous technological breakthroughs, and the implementation of medical insurance payments [1] Event Highlights - The conference features several "firsts," including the first large-scale multi-track BCI competition, the establishment of a BCI developer forum, and a dedicated investment cooperation sub-forum [1] - The BCI competition includes four tracks: emotion perception, fatigue monitoring, brain-controlled robotic arms, and brain-controlled racing cars, with 63 teams participating and 40 advancing to the finals [1][2] Policy Support - There has been a surge in favorable policies for the BCI sector, including a joint implementation opinion from seven departments in July and the inclusion of BCI in the 15th Five-Year Plan by the Central Committee in October [3] - Various regions, including Beijing, Shanghai, Sichuan, and Shandong, are actively promoting BCI technology and industry development, with Jiangxi Province recently issuing measures to accelerate clinical trials [3] Company Developments - The BCI industry is at a pivotal growth stage, with several companies, including A-share listed firms, actively investing in the BCI value chain [4] - Xiangyu Medical has identified BCI as a key strategic research direction, integrating BCI technology into rehabilitation equipment [4] - Chengdu Huayi is leveraging its integrated circuit design advantages to provide foundational hardware components for BCI technology, collaborating with universities on key projects [5] - Companies are also pursuing strategic investments in the BCI space, such as Dao's Technology investing in Qiang Brain Technology to enhance its capabilities in medical rehabilitation and human-computer interaction [5]

Core Viewpoint - Chengdu Huami (688709.SH) is actively developing brain-computer interface technology, focusing on providing foundational hardware components for signal processing, including high-precision ADCs and low-power FPGAs and MCUs [1] Group 1: Company Developments - The company has leveraged its integrated circuit design advantages to establish a presence in the brain-computer interface sector [1] - Key projects in collaboration with universities such as Shanghai Jiao Tong University and Tianjin University have been completed, covering both invasive and non-invasive brain-computer interface signal chain requirements [1] - The company maintains strong collaborative relationships with several higher education institutions and research organizations, including University of Electronic Science and Technology of China, Xi'an University of Electronic Science and Technology, and National University of Defense Technology [1] Group 2: Future Plans - The company will closely monitor trends in cutting-edge technology and explore new collaboration opportunities in line with its R&D strengths [1] - The company emphasizes the importance of industry-academia-research collaborative innovation and will fulfill information disclosure obligations for any new cooperation plans [1]

Group 1 - The stock price of Chipsea Technology is reported at 38.38 yuan, down by 1.09 yuan from the previous trading day, with a trading volume of 65,874 hands and a transaction amount of 259 million yuan, resulting in a turnover rate of 4.63% [1] - Chipsea Technology specializes in high-precision ADC, high-performance MCU, measurement algorithms, and IoT solutions, with products widely used in smart terminals, smart homes, computers, automotive electronics, and industrial control [1] - In 2024, the company achieved a revenue of 702 million yuan, with a year-on-year growth of 137.11% in analog signal chain chip sales and a 67.63% increase in MCU chip business [1] Group 2 - On August 13, the company held a board meeting and approved a proposal to issue H-shares and list on the main board of the Hong Kong Stock Exchange, aiming to deepen its international strategic layout [1] - The company stated it will fully consider the interests of existing shareholders and will choose an appropriate time to complete the issuance and listing within the validity period of the shareholders' meeting resolution [1] - On August 14, the net outflow of main funds was 9.8688 million yuan, accounting for 0.18% of the circulating market value, with a cumulative net outflow of 16.9413 million yuan over the past five days, representing 0.31% of the circulating market value [1]

Core Viewpoint - The company is actively developing brain-computer interface technology, leveraging its integrated circuit design advantages to focus on providing foundational hardware components for signal processing [1] Group 1: Technology Development - The company utilizes high-precision ADC (Analog-to-Digital Converter) for neural signal acquisition and employs low-power FPGA (Field-Programmable Gate Array) and MCU (Microcontroller) for signal post-processing [1] - The technology development covers both invasive and non-invasive brain-computer interface signal chain requirements, including the research and application of 24-bit sigma-delta high-precision ADC and low-power MCU chips [1] Group 2: Collaborations and Projects - The company has completed part of the acceptance for key projects in collaboration with universities such as Shanghai Jiao Tong University and Tianjin University [1] - The company will continue to monitor technological trends and market demands while steadily advancing its product layout based on its R&D capabilities [1] Group 3: Information Disclosure - The company commits to adhering to information disclosure regulations and will announce specific progress in a timely manner, relying on official disclosures for accurate information [1]

Core Viewpoint - Chengdu Huami has made significant advancements in the brain-computer interface technology sector, focusing on providing foundational hardware components for signal processing [1] Group 1: Company Developments - The company leverages its integrated circuit design advantages to develop solutions in the brain-computer interface field [1] - Chengdu Huami utilizes high-precision ADCs (Analog-to-Digital Converters) for neural signal acquisition and employs low-power FPGAs (Field-Programmable Gate Arrays) and MCUs (Microcontrollers) for signal post-processing [1] - The company collaborates with prestigious universities such as Shanghai Jiao Tong University and Tianjin University on key projects, some of which have already completed acceptance testing [1] Group 2: Technology and Products - The technology developed by the company covers the full signal chain requirements for both invasive and non-invasive brain-computer interfaces [1] - The product offerings include 24-bit sigma-delta structure high-precision ADCs and low-power MCUs, which are crucial for the development and application of brain-computer interface technologies [1]